Valuation: China Resources Pharmaceutical Group Limited

Market Cap 27.61B 3.52B 3.19B 2.95B 2.66B 5.02B 332B 5.19B 35.44B 14.05B 177B 13.21B 12.93B 563B P/E 2026 *
5.64x
P/E 2027 * 5.29x
Enterprise Value 76.85B 9.8B 8.88B 8.21B 7.41B 13.96B 924B 14.45B 98.62B 39.11B 493B 36.76B 35.98B 1,566B EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.21x
Free-Float
29.17%
Yield 2026 *
4.63%
Yield 2027 * 5.01%
1 day+2.16%
1 week-3.75%
Current month-3.13%
1 month-2.50%
3 months-7.42%
6 months-6.46%
Current year+0.90%
1 week 4.36
Extreme 4.365
4.68
1 month 4.36
Extreme 4.365
4.76
Current year 4.22
Extreme 4.22
6.53
1 year 4.22
Extreme 4.22
6.53
3 years 4.22
Extreme 4.22
7.11
5 years 3.18
Extreme 3.18
8.13
10 years 3.18
Extreme 3.18
13.16
Manager TitleAgeSince
President 47 26/08/2025
Director of Finance/CFO 54 13/06/2023
Corporate Secretary - 15/12/2025
Director TitleAgeSince
Director/Board Member 59 01/06/2016
Director/Board Member 70 20/06/2016
Chairman 55 29/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
1/4/20 Other

Chief Executive Officer

200,000 0.0032%
31/3/20 Other

Chief Executive Officer

100,000 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+2.16%-3.75%-9.11%-8.92% 3.52B
+1.14%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
+0.31%+0.87%+40.88%+70.83% 386B
+0.55%+0.70%+59.02%+45.79% 364B
+0.72%+1.24%+27.74%+62.35% 302B
-0.01%-0.70%+2.76%+37.39% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average +0.54%+1.29%+30.76%+75.37% 430B
Weighted average by Cap. +0.59%+3.25%+37.52%+99.33%

Financials

2026 *2027 *
Net sales 328B 41.78B 37.87B 35.02B 31.6B 59.55B 3,940B 61.65B 421B 167B 2,105B 157B 153B 6,680B 341B 43.43B 39.36B 36.41B 32.85B 61.9B 4,095B 64.08B 437B 173B 2,188B 163B 160B 6,944B
Net income 4.82B 615M 557M 515M 465M 876M 57.98B 907M 6.19B 2.45B 30.97B 2.31B 2.26B 98.3B 5.18B 660M 598M 553M 499M 941M 62.23B 974M 6.65B 2.64B 33.24B 2.48B 2.42B 106B
Net Debt 49.24B 6.28B 5.69B 5.26B 4.75B 8.94B 592B 9.26B 63.19B 25.06B 316B 23.55B 23.05B 1,003B 42.53B 5.42B 4.91B 4.54B 4.1B 7.73B 511B 8B 54.58B 21.64B 273B 20.34B 19.91B 867B
Projected Income Statement - Annual - China Resources Pharmaceutical Group Limited
Logo China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.
Employees
84,000
Date Price Change Volume
16/11/26 HK$4.490 +2.16% 4,459,736
13/11/26 HK$4.395 -1.79% 5,785,000
12/11/26 HK$4.475 -1.43% 5,475,500
11/11/26 HK$4.540 -1.84% 8,397,739
10/11/26 HK$4.625 -0.86% 4,366,500
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - China Resources Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
4.395HKD
Average target price
6.489HKD
Spread / Average Target
+47.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - China Resources Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 3320 Stock